Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jun 14, 2021 9:26pm
63 Views
Post# 33386341

RE:topped 7$ or 8$ on FDA news dumbass:)

RE:topped 7$ or 8$ on FDA news dumbass:)Liar, provide one link showing it topped $8 .

You can't, because it didn't.  


Newcamo wrote:

It Will do it again on the cash inflow of +- 100M$...
 

Newcamo (62)
18 minutes ago
22 Reads
Post# 33382367

RE:Holding the line

this is high beta, u can trade the swings, once they cash in the more or less 100M$ it will swing north hard.... u can trade for this short term, or buy here and hold for next partnership. It moved hard on the FDA news, it will do it again on the cash inflow from the voucher. Whatever the strategy, there is no risk buying here, and at least go for the swing  on the cash inflow (100M$).



<< Previous
Bullboard Posts
Next >>